摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-((1S,2S)-2-氨基-1,2-双(4-甲氧基苯基)乙基)-4-甲基苯磺酰胺 | 887924-07-4

中文名称
N-((1S,2S)-2-氨基-1,2-双(4-甲氧基苯基)乙基)-4-甲基苯磺酰胺
中文别名
——
英文名称
(1S,2S)-N-p-toluenesulfonyl-1,2-di(4-methoxyphenyl)ethylenediamine
英文别名
(S,S)-TsDAEN;N-((1S,2S)-2-Amino-1,2-bis(4-methoxyphenyl)ethyl)-4-methylbenzenesulfonamide;N-[(1S,2S)-2-amino-1,2-bis(4-methoxyphenyl)ethyl]-4-methylbenzenesulfonamide
N-((1S,2S)-2-氨基-1,2-双(4-甲氧基苯基)乙基)-4-甲基苯磺酰胺化学式
CAS
887924-07-4
化学式
C23H26N2O4S
mdl
——
分子量
426.536
InChiKey
QECIBWAUSHWNEP-GOTSBHOMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    603.6±65.0 °C(Predicted)
  • 密度:
    1.227±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    30
  • 可旋转键数:
    8
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    99
  • 氢给体数:
    2
  • 氢受体数:
    6

安全信息

  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H315,H319,H335

反应信息

点击查看最新优质反应信息

文献信息

  • ASYMMETRIC CATALYTIC REDUCTION OF OXCARBAZEPINE
    申请人:BIAL - PORTELA & C.A., S.A.
    公开号:US20170190668A1
    公开(公告)日:2017-07-06
    A process for preparing (S)-(+)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide or (R)-(−)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide, by reduction of oxcarbazepine in the presence of a catalyst and a hydride source is disclosed. The catalyst is prepared from a combination of [RuX 2 (L)] 2 wherein X is chlorine, bromine or iodine, and L is an aryl or aryl-aliphatic ligand, with a ligand of formula (A) or formula (B): wherein R 1 is chosen from C 1-6 alkoxy and C 1-6 alkyl, n is a number from 0 to 5, and when n is a number from 2 to 5, R 1 can be the same or different, and R 2 is alkyl, substituted alkyl, aryl, substituted aryl, alkaryl or substituted alkaryl. The hydride source is either NR 3 R 4 R 5 and formic acid, [R 3 R 4 R 5 NH][OOCH] and optionally formic acid, or [M][OOCH] x and formic acid, wherein R 3 , R 4 and R 5 are C 1-6 alkyl, M is an alkali metal or alkaline earth metal and x is 1 or 2. A pH from 6.5 to 8 is maintained during the process.
    本发明公开了一种制备(S)-(+)-10,11-二氢-10-羟基-5H-二苯并[b,f]氮杂七环-5-羧酰胺或(R)-(-)-10,11-二氢-10-羟基-5H-二苯并[b,f]氮杂七环-5-羧酰胺的方法,通过在催化剂和氢化物来源的存在下还原奥卡巴。所述催化剂由[RuX2(L)]2的组合物制备而成,其中X为,L为芳基或芳基-脂肪基配体,并与式(A)或式(B)的配体组合,其中R1选自C1-6烷氧基和C1-6烷基,n为0至5的数字,当n为2至5的数字时,R1可以相同或不同,而R2为烷基、取代烷基、芳基、取代芳基、烷芳基或取代烷芳基。氢化物来源可以是NR3R4R5和甲酸、[R3R4R5NH][OOCH]和可选的甲酸,或[M][OOCH]x和甲酸,其中R3、R4和R5为C1-6烷基,M为碱属或碱土属,x为1或2。在过程中维持pH值在6.5至8之间。
  • Asymmetric catalytic reduction of oxcarbazepine
    申请人:Bial-Portela & CA, S.A.
    公开号:EP2319836A1
    公开(公告)日:2011-05-11
    A process for preparing (S)-(+)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide or (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide, by reduction of oxcarbazepine in the presence of a catalyst and a hydride source is disclosed. The catalyst is prepared from a combination of [RuX2(L)]2 wherein X is chlorine, bromine or iodine, and L is an aryl or aryl-aliphatic ligand, with a ligand of formula (A) or formula (B): wherein R1 is chosen from C1-6 alkoxy and C1-6 alkyl, n is a number from 0 to 5, and when n is a number from 2 to 5, R1 can be the same or different, and R2 is alkyl, substituted alkyl, aryl, substituted aryl, alkaryl or substituted alkaryl. The hydride source is either NR3R4R5 and formic acid, [R3R4R5NH][OOCH] and optionally formic acid, or [M][OOCH]x and formic acid, wherein R3, R4 and R5 are C1-6 alkyl, M is an alkali metal or alkaline earth metal and x is 1 or 2. A pH from 6.5 to 8 is maintained during the process.
    本发明公开了一种在催化剂和氢化物源存在下通过还原奥卡西平制备(S)-(+)-10,11-二氢-10-羟基-5H-二苯并/b,f/氮杂卓-5-甲酰胺或(R)-(-)-10,11-二氢-10-羟基-5H-二苯并/b,f/氮杂卓-5-甲酰胺的工艺。该催化剂由[RuX2(L)]2(其中 X 为,L 为芳基或芳基脂肪族配体)与式(A)或式(B)配体的组合制备而成: 其中 R1 选自 C1-6 烷氧基和 C1-6 烷基,n 为 0 至 5 的数字,当 n 为 2 至 5 的数字时,R1 可以相同或不同,R2 为烷基、取代烷基、芳基、取代芳基、烷芳基或取代烷芳基。氢化物源为 NR3R4R5 和甲酸、[R3R4R5NH][OOCH]和可选甲酸或 [M][OOCH]x 和甲酸,其中 R3、R4 和 R5 为 C1-6 烷基,M 为碱属或碱土属,x 为 1 或 2。在此过程中,pH 值保持在 6.5 至 8 之间。
  • WO2007/12793
    申请人:——
    公开号:——
    公开(公告)日:——
  • Sulphonylated Diphenylethylenediamines, Method For Their Preparation And Use In Transfer Hydrogenation Catalysis
    申请人:Dominguez Beatriz
    公开号:US20080081930A1
    公开(公告)日:2008-04-03
    A diamine of formula (I) is described, in which A is hydrogen or a saturated or unsaturated C1-C20 alkyl group or an aryl group; B is a substituted or unsubstituted C1-C20 alkyl, cycloalkyl, alkaryl, alkaryl or aryl group or an alkylamino group and at least one of X 1 , X 2 , Y 1 , Y 2 or Z is a C1-C10 alkyl, cycloalkyl, alkaryl, aralkyl or alkoxy substituting group. The chiral diamine may be used to prepare catalysts suitable for use in transfer hydrogenation reactions.
  • Sulphonylated Diphenylethylenediamines, Method for Their Preparation and Use in Transfer Hydrogenation Catalysis
    申请人:Dominguez Beatriz
    公开号:US20120077973A1
    公开(公告)日:2012-03-29
    A diamine of formula (I) is described in which A is hydrogen or a saturated or unsaturated C1-C20 alkyl group or an aryl group; B is a substituted or unsubstituted C1-C20 alkyl, cycloalkyl, alkaryl, alkaryl or aryl group or an alkylamino group and at least one of X 1 , X 2 , Y 1 , Y 2 or Z is a C1-C10 alkyl, cycloalkyl, alkaryl, aralkyl or alkoxy substituting group. The chiral diamine may be used to prepare catalysts suitable for use in transfer hydrogenation reactions.
查看更多

同类化合物

(E,Z)-他莫昔芬N-β-D-葡糖醛酸 (E/Z)-他莫昔芬-d5 (4S,5R)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S,5R,5''R)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (4R,5S)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4R,4''R,5S,5''S)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (1R,2R)-2-(二苯基膦基)-1,2-二苯基乙胺 鼓槌石斛素 黄子囊素 高黄绿酸 顺式白藜芦醇三甲醚 顺式白藜芦醇 顺式己烯雌酚 顺式-白藜芦醇3-O-beta-D-葡糖苷酸 顺式-桑皮苷A 顺式-曲札芪苷 顺式-二苯乙烯 顺式-beta-羟基他莫昔芬 顺式-a-羟基他莫昔芬 顺式-3,4',5-三甲氧基-3'-羟基二苯乙烯 顺式-1-(3-甲基-2-萘基)-2-(2-萘基)乙烯 顺式-1,2-双(三甲基硅氧基)-1,2-双(4-溴苯基)环丙烷 顺式-1,2-二苯基环丁烷 顺-均二苯乙烯硼酸二乙醇胺酯 顺-4-硝基二苯乙烯 顺-1-异丙基-2,3-二苯基氮丙啶 非洲李(PRUNUSAFRICANA)树皮提取物 阿非昔芬 阿里可拉唑 阿那曲唑二聚体 阿托伐他汀环氧四氢呋喃 阿托伐他汀环氧乙烷杂质 阿托伐他汀环(氟苯基)钠盐杂质 阿托伐他汀环(氟苯基)烯丙基酯 阿托伐他汀杂质D 阿托伐他汀杂质94 阿托伐他汀杂质7 阿托伐他汀杂质5 阿托伐他汀内酰胺钠盐杂质 阿托伐他汀中间体M4 阿奈库碘铵 锌(II)(苯甲醛)(四苯基卟啉) 银松素 铜酸盐(5-),[m-[2-[2-[1-[4-[2-[4-[[4-[[4-[2-[4-[4-[2-[2-(羧基-kO)苯基]二氮烯基-kN1]-4,5-二氢-3-甲基-5-(羰基-kO)-1H-吡唑-1-基]-2-硫代苯基]乙烯基]-3-硫代苯基]氨基]-6-(苯基氨基)-1,3,5-三嗪-2-基]氨基]-2-硫代苯基]乙烯基]-3-硫代 铒(III) 离子载体 I 铀,二(二苯基甲酮)四碘- 钾钠2,2'-[(E)-1,2-乙烯二基]二[5-({4-苯胺基-6-[(2-羟基乙基)氨基]-1,3,5-三嗪-2-基}氨基)苯磺酸酯](1:1:1) 钠{4-[氧代(苯基)乙酰基]苯基}甲烷磺酸酯 钠;[2-甲氧基-5-[2-(3,4,5-三甲氧基苯基)乙基]苯基]硫酸盐 钠4-氨基二苯乙烯-2-磺酸酯